Table 1.
Entry | Inhibitor | Ki (nM) | IC50 (nM)a |
---|---|---|---|
1 | 0.15 ± 0.019 | ndb | |
2 | 0.16 ± 0.04 | 30 ± 1 | |
3 | 0.16 ± 0.011 | nd | |
4 | 0.026 ± 0.012 | 4.9 ± 0.3 | |
5 | 0.81 ± 0.12 | nd | |
6 | 0.74 ± 0.15 | nd | |
7 | 27 ± 0.81 | nd | |
8 | 0.041 ± 0.002 | 3.4 ± 0.7 | |
9 | 16 ± 2.2 | nd | |
10 | 33 ± 1.9 | nd | |
11 | 6.3 ± 0.57 | >1000 | |
12 | 1.9 ± 0.2 | >1000 | |
13 | 19 ± 0.76 | >1000 | |
SQVc | - | - | 16 ± 3 |
APVd | - | - | 27 ± 6 |
MT-2 human T-lymphoid cells exposed to HIV-1LAI
nd = not determined
SQV = saquinavir
APV = amprenavir.